Anmin Liang is a scholar working on Oncology, Epidemiology and Molecular Biology.
According to data from OpenAlex, Anmin Liang has authored 13 papers receiving a total of 894 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 5 papers in Epidemiology and 4 papers in Molecular Biology. Recurrent topics in Anmin Liang's work include Hepatitis B Virus Studies (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers) and Cancer-related Molecular Pathways (3 papers). Anmin Liang is often cited by papers focused on Hepatitis B Virus Studies (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers) and Cancer-related Molecular Pathways (3 papers). Anmin Liang collaborates with scholars based in China, Canada and United Kingdom. Anmin Liang's co-authors include Xuetao Cao, Lun–Xiu Qin, Xiaobing Wu, Guoshan Ding, Shi‐Mei Zhuang, Qiongzhu Dong, Qinghua Zhang, Zhengxin Wang, Limin Zheng and Li Lin and has published in prestigious journals such as Gastroenterology, Hepatology and Cancer Cell.
In The Last Decade
Anmin Liang
13 papers
receiving
881 citations
Hit Papers
What are hit papers?
Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Identification of miRNomes in Human Liver and Hepatocellular Carcinoma Reveals miR-199a/b-3p as Therapeutic Target for Hepatocellular Carcinoma
2011600 citationsJin Hou, Li Lin et al.Cancer Cellprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of Anmin Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anmin Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anmin Liang more than expected).
This network shows the impact of papers produced by Anmin Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anmin Liang. The network helps show where Anmin Liang may publish in the future.
Co-authorship network of co-authors of Anmin Liang
This figure shows the co-authorship network connecting the top 25 collaborators of Anmin Liang.
A scholar is included among the top collaborators of Anmin Liang based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Anmin Liang. Anmin Liang is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
13 of 13 papers shown
1.
Hou, Jin, Li Lin, Weiping Zhou, et al.. (2011). Identification of miRNomes in Human Liver and Hepatocellular Carcinoma Reveals miR-199a/b-3p as Therapeutic Target for Hepatocellular Carcinoma. Cancer Cell. 19(2). 232–243.600 indexed citations breakdown →
Luo, Xiaoling, et al.. (2008). [Effects of hMIP-1beta gene modification on in vivo tumorigenicity and vaccine efficacy of tumor cells].. PubMed. 30(2). 97–102.1 indexed citations
Liang, Anmin, et al.. (2008). [Dendritic cell vaccine modified by murine mAFP gene enhances immunoprotective effect on liver carcinogenesis and tumor development in mice].. PubMed. 30(4). 250–4.1 indexed citations
8.
Liang, Anmin. (2007). Clinical Study on Xiangshu Zhitong Ding in Treating Cancerous Pain. Lishizhen Medicine and Materia Medica Research.1 indexed citations
9.
Luo, Xiaoling, Yizhi Yu, Anmin Liang, et al.. (2004). Intratumoral expression of MIP-1beta induces antitumor responses in a pre-established tumor model through chemoattracting T cells and NK cells.. PubMed. 1(3). 199–204.32 indexed citations
10.
Liang, Anmin, et al.. (2004). [Comprehensive therapy for primary liver cancer: a report of 607 cases].. PubMed. 23(2). 211–4.2 indexed citations
11.
Yin-nong, Zhao, Ji Cao, Feixiang Wu, et al.. (2004). [Expression and significance of EGF mRNA and EGFR mRNA in hepatocellular carcinoma].. PubMed. 23(7). 762–6.20 indexed citations
12.
Yang, Bing‐Hui, Jinglin Xia, Li‐Wen Huang, et al.. (2004). Changed clinical aspects of primary liver cancer in China during the past 30 years.. PubMed. 3(2). 194–8.15 indexed citations
13.
Mo, Qinguo, et al.. (2003). [Surgery-predominant comprehensive therapy for 134 patients with small hepatocellular carcinoma].. PubMed. 22(2). 189–91.5 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.